| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038742165 |
| P356 | DOI | 10.1038/NM1530 |
| P698 | PubMed publication ID | 17206148 |
| P5875 | ResearchGate publication ID | 6595320 |
| P50 | author | Kypros Nicolaides | Q1795145 |
| Tze Kin Lau | Q51980546 | ||
| Yongjie Jin | Q125193732 | ||
| Ageliki Gerovassili | Q125194218 | ||
| P2093 | author name string | Chunming Ding | |
| Charles R Cantor | |||
| Nancy B Y Tsui | |||
| Macy M S Heung | |||
| Rossa W K Chiu | |||
| Y M Dennis Lo | |||
| Tse N Leung | |||
| P2860 | cites work | Amniocentesis and chorionic villus sampling for prenatal diagnosis | Q24247990 |
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| Simultaneous quantitative and allele-specific expression analysis with real competitive PCR | Q24798878 | ||
| Prenatal diagnosis. An earlier look at baby's genes | Q28270499 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Down syndrome and cell-free fetal DNA in archived maternal serum. | Q31119002 | ||
| MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis | Q33197500 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Invasive prenatal diagnostic techniques. | Q34501680 | ||
| Placental mRNA in maternal plasma: prospects for fetal screening | Q34955670 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? | Q35010397 | ||
| PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
| D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. | Q36773513 | ||
| Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling | Q43073656 | ||
| Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood | Q46167117 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. | Q52022916 | ||
| Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy | Q57004459 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma | Q63359242 | ||
| First-trimester screening for trisomies 21 and 18 | Q79133560 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 218-223 | |
| P577 | publication date | 2007-01-07 | |
| P1433 | published in | ??? | Q1633234 |
| P1476 | title | Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | |
| P478 | volume | 13 |
| Q54986845 | A Profile of Dennis Lo, DM, DPhil, FRCP, FRCPath, FRS. |
| Q56772308 | A new era in prenatal testing: are we prepared? |
| Q37433730 | A new method for non-invasive prenatal diagnosis of Down syndrome using MeDIP real time qPCR. |
| Q51346655 | A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. |
| Q34657423 | Advances in MALDI mass spectrometry in clinical diagnostic applications |
| Q49161578 | An offer you can't refuse? Ethical implications of non-invasive prenatal diagnosis |
| Q54626997 | Application of multiplex SNaPshot assay in measurement of PLAC4 RNA-SNP allelic ratio for noninvasive prenatal detection of trisomy 21. |
| Q37801660 | Application of proteomics to prenatal screening and diagnosis for aneuploidies. |
| Q49403301 | Association between DSCR4 gene methylation in plasma in early pregnancy and Down's syndrome |
| Q38101277 | Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies |
| Q27025112 | Biomarkers for ectopic pregnancy and pregnancy of unknown location |
| Q56765605 | Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome |
| Q34277918 | Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction |
| Q38371846 | Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation |
| Q37169269 | Cell-free fetal DNA and non-invasive prenatal diagnosis |
| Q39778751 | Cell-free fetal nucleic acids as prenatal biomarkers |
| Q34233631 | Cell-free seminal mRNA and microRNA exist in different forms |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q46446186 | Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors |
| Q88990659 | Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis |
| Q37849710 | Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood? |
| Q37222110 | Cytogenetics and the evolution of medical genetics |
| Q38089061 | Detecting genomic imbalances in prenatal diagnosis: main hurdles and recent advances |
| Q28247266 | Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis |
| Q35958986 | Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus |
| Q34921561 | Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? |
| Q58920488 | Development of a novel reference plasmid for accurate quantification of genetically modified Kefeng6 rice DNA in food and feed samples |
| Q34239768 | Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies |
| Q35916813 | Digital PCR for the molecular detection of fetal chromosomal aneuploidy |
| Q34660121 | Discovery and characterization of protein-modifying natural products by MALDI mass spectrometry reveal potent SIRT1 and p300 inhibitors |
| Q35020525 | Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease |
| Q37887528 | ECHO probes: a concept of fluorescence control for practical nucleic acid sensing. |
| Q36384651 | Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma |
| Q34558118 | Epigenetic approaches for the detection of fetal DNA in maternal plasma |
| Q33797671 | Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker |
| Q35890325 | Explore the dynamic alternation of gene PLAC4 mRNA expression levels in maternal plasma in second trimester for nonivasive detection of trisomy 21 |
| Q59001540 | Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis |
| Q37948857 | Fetal nucleic acids in maternal blood: the promises |
| Q34168875 | Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. |
| Q45875805 | Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers |
| Q26863327 | Free DNA--new potential analyte in clinical laboratory diagnostics? |
| Q34286705 | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges |
| Q46556601 | Get ready for the flood of fetal gene screening |
| Q31104630 | High Levels of Sample-to-Sample Variation Confound Data Analysis for Non-Invasive Prenatal Screening of Fetal Microdeletions |
| Q55348084 | Human plasma and serum extracellular small RNA reference profiles and their clinical utility. |
| Q91069740 | Identification of a de novo fetal variant in osteogenesis imperfecta by targeted sequencing-based noninvasive prenatal testing |
| Q40158974 | Investigation of biological factors influencing the placental mRNA profile in maternal plasma |
| Q38181003 | Lab-on-a-chip technology: impacting non-invasive prenatal diagnostics (NIPD) through miniaturisation |
| Q33737845 | MALDI-TOF MS in Prenatal Genomics |
| Q55424345 | MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT. |
| Q38973677 | Measuring circulating placental RNAs to non-invasively assess the placental transcriptome and to predict pregnancy complications. |
| Q37061065 | Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia |
| Q37988359 | MicroRNA and its roles in esophageal cancer. |
| Q47425702 | Molecular roles and function of circular RNAs in eukaryotic cells |
| Q81060866 | Mutations, structural variations, and genome-wide resequencing: where to from here in our understanding of disease and evolution? |
| Q37181536 | Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment? |
| Q28748932 | Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms |
| Q38088834 | Non-coding RNA and DNA as epigenetic biomarkers for pre-eclampsia |
| Q34149751 | Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities |
| Q92823613 | Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing |
| Q34482155 | Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study |
| Q37809306 | Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age |
| Q36079264 | Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. |
| Q80489429 | Non-invasive prenatal diagnosis of Down's syndrome |
| Q94534406 | Non-invasive prenatal diagnosis of Down's syndrome |
| Q36424760 | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications |
| Q79756522 | Non-invasive prenatal diagnosis of fetal aneuploidies |
| Q36117921 | Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis |
| Q38114375 | Non-invasive prenatal testing for aneuploidy: current status and future prospects |
| Q34496747 | Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies |
| Q38549770 | Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA |
| Q22242878 | Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 |
| Q24657306 | Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood |
| Q33665478 | Noninvasive in vivo monitoring of tissue-specific global gene expression in humans |
| Q47785370 | Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms |
| Q37998943 | Noninvasive prenatal diagnosis empowered by high-throughput sequencing |
| Q36225300 | Noninvasive prenatal diagnosis of Down syndrome in samples from Southwest Chinese gravidas using pregnant plasma placental RNA allelic ratio |
| Q37592253 | Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies |
| Q37010246 | Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma |
| Q28742844 | Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing |
| Q28729130 | Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA |
| Q37000915 | Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma |
| Q38002933 | Noninvasive prenatal diagnosis of monogenic disorders |
| Q37705437 | Noninvasive prenatal diagnosis using ccffDNA in maternal blood: state of the art. |
| Q56776996 | Noninvasive prenatal tests for Down syndrome are near |
| Q43861652 | Nucleic acid-based non-invasive prenatal diagnosis of genetic skin diseases: are we ready? |
| Q92839651 | PLAC4 mRNA SNP in non-invasive prenatal testing of Down syndrome |
| Q58029252 | PRENATAL SCREENING AND DIAGNOSIS OF FETAL CHROMOSOMAL ABNORMALITIES – DILEMMA BETWEEN BEST EVIDENCE-BASED MODEL AND PRACTICABILITY |
| Q33466029 | Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood |
| Q38954748 | Prenatal and pre-implantation genetic diagnosis |
| Q39850180 | Prenatal diagnosis of fetal aneuploidies: post-genomic developments |
| Q54269871 | Prenatal diagnosis of trisomy 21 by quantitatively pyrosequencing heterozygotes using amniotic fluid as starting material of PCR. |
| Q36673937 | Prenatal diagnosis: progress through plasma nucleic acids |
| Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
| Q84836506 | Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA |
| Q29619605 | RNA sequencing: advances, challenges and opportunities |
| Q51025922 | Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis. |
| Q63359216 | Reply to “STOX1 is not imprinted and is not likely to be involved in preeclampsia” |
| Q44843905 | Restriction endonuclease-mediated real-time digestion-PCR for somatic mutation detection |
| Q39985314 | Saliva as a diagnostic tool for periodontal disease: current state and future directions |
| Q36691563 | Salivary mRNA targets for cancer diagnostics |
| Q36954067 | Second-generation non-invasive high-throughput DNA sequencing technology in the screening of Down's syndrome in advanced maternal age women |
| Q21144238 | Serum microRNAs are promising novel biomarkers |
| Q34295095 | Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre |
| Q36591795 | Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome |
| Q33770229 | Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome |
| Q34230033 | Systematic identification of spontaneous preterm birth-associated RNA transcripts in maternal plasma |
| Q90372343 | The 100 most-cited articles on prenatal diagnosis: A bibliometric analysis |
| Q35667241 | The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis |
| Q35845545 | The high incidence of STR D21S1446 homozygosity in Han and She populations living in South Eastern China |
| Q34272104 | The triple test as a screening technique for Down syndrome: reliability and relevance |
| Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
| Q38148966 | Transcriptomics: advances and approaches |
| Q33512678 | Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register |
| Q50488961 | Unique monoclonal antibodies specifically bind surface structures on human fetal erythroid blood cells |
| Q33538996 | Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome. |
| Q84093944 | [Non invasive diagnosis of fetal diseases by maternal blood tests] |
Search more.